Predictors for the prolonged R wave peak time among patients with arterial hypertension

Göksel Çinier1, Ahmet Seyda Yılmaz2, Ahmet İlker Tekkesin1

  • 1Department of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.

Insights

Epicardial fat tissue (EFT) and fragmented QRS (fQRS) predict prolonged R wave peak time (RWPT) in hypertension patients. Myocardial fibrosis may significantly impact ventricular activation time more than increased left ventricular mass.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Hypertension Research

Background:

  • Hypertension (HT) is a widespread condition linked to severe cardiovascular events.
  • Pressure overload in HT triggers significant structural and electrical remodeling of the ventricular myocardium.
  • Increased left ventricular mass (LVM) and myocardial fibrosis are associated with prolonged R wave peak time (RWPT), indicating electrical remodeling.

Purpose of the Study:

  • To identify predictors of prolonged RWPT in patients with a history of hypertension.
  • To investigate the relationship between cardiac structural and electrical changes and RWPT in hypertensive individuals.

Main Methods:

  • A cohort of 237 patients with arterial HT was studied.
  • Standard 12-lead surface electrocardiography (ECG) and transthoracic echocardiography (TTE) were performed.
  • Epicardial fat tissue (EFT), left ventricular mass index (LVMI), and fragmented QRS (fQRS) were assessed to predict prolonged RWPT (upper limit 40 ms).

Main Results:

  • The mean RWPT was 41.9±10.8 ms, with 55 patients exhibiting prolonged RWPT.
  • Univariate analysis showed EFT, LVMI, and fQRS were associated with prolonged RWPT.
  • Multivariate analysis identified EFT (OR 1.211) and fQRS (OR 2.796) as independent predictors of prolonged RWPT.

Conclusions:

  • Epicardial fat tissue (EFT) and fragmented QRS (fQRS) are significant predictors of prolonged RWPT in patients with hypertension.
  • These findings suggest that myocardial fibrosis, as indicated by EFT and fQRS, may have a greater impact on ventricular activation time than increased LVM in hypertensive patients.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
114
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
888
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
172
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
603
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
1.0K